| The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8 JE De Larco, BRK Wuertz, LT Furcht Clinical Cancer Research 10 (15), 4895-4900, 2004 | 498 | 2004 |
| A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells JE De Larco, BRK Wuertz, KA Rosner, SA Erickson, DE Gamache, ... The American journal of pathology 158 (2), 639-646, 2001 | 216 | 2001 |
| Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents JE De Larco, BRK Wuertz, JC Manivel, LT Furcht Cancer Research 61 (7), 2857-2861, 2001 | 103 | 2001 |
| Atypical methylation of the interleukin-8 gene correlates strongly with the metastatic potential of breast carcinoma cells JE De Larco, BRK Wuertz, D Yee, BL Rickert, LT Furcht Proceedings of the National Academy of Sciences 100 (24), 13988-13993, 2003 | 99 | 2003 |
| Cigarette Smoke Activates NFκB and Induces Muc5b Expression in Mouse Middle Ear Cells D Preciado, J Lin, B Wuertz, M Rose The Laryngoscope 118 (3), 464-471, 2008 | 48 | 2008 |
| Tobacco carcinogen mediated up‐regulation of AP‐1 dependent pro‐angiogenic cytokines in head and neck carcinogenesis WG Swenson, BRK Wuertz, FG Ondrey Molecular carcinogenesis 50 (9), 668-679, 2011 | 43 | 2011 |
| Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions JS Gutkind, AA Molinolo, X Wu, Z Wang, D Nachmanson, O Harismendy, ... JCI insight 6 (17), 2021 | 39 | 2021 |
| Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker Y Yang, NL Rhodus, FG Ondrey, BRK Wuertz, X Chen, Y Zhu, TJ Griffin PLoS One 9 (4), e95389, 2014 | 33 | 2014 |
| PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR G Harris, RA Ghazallah, D Nascene, B Wuertz, FG Ondrey Otolaryngology–Head and Neck Surgery 133 (5), 695-701, 2005 | 30 | 2005 |
| TNF‐α Drives Matrix Metalloproteinase‐9 in Squamous Oral Carcinogenesis L Hohberger, BRK Wuertz, H Xie, T Griffin, F Ondrey The Laryngoscope 118 (8), 1395-1399, 2008 | 29 | 2008 |
| Fixed-dose combinations of pioglitazone and metformin for lung cancer prevention DE Seabloom, AR Galbraith, AM Haynes, JD Antonides, BR Wuertz, ... Cancer Prevention Research 10 (2), 116-123, 2017 | 28 | 2017 |
| Cigarette smoke condensate induces nuclear factor kappa‐b activity and proangiogenic growth factors in aerodigestive cells J Rohrer, BRK Wuertz, F Ondrey The Laryngoscope 120 (8), 1609-1613, 2010 | 20 | 2010 |
| Interleukin‐8 production in response to tumor necrosis factor‐alpha by cholesteatoma keratinocytes in cell culture CW Hilton, FG Ondrey, BR Wuertz, SC Levine The Laryngoscope 121 (2), 372-374, 2011 | 19 | 2011 |
| The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: The role of nuclear factor–κB inhibition EE Caicedo-Granados, BR Wuertz, PH Marker, GS Lee, FG Ondrey Archives of Otolaryngology–Head & Neck Surgery 137 (8), 799-805, 2011 | 17 | 2011 |
| Chemoprevention of lung carcinogenesis by dietary nicotinamide and inhaled budesonide AR Galbraith, DE Seabloom, BR Wuertz, JD Antonides, VE Steele, ... Cancer Prevention Research 12 (2), 69-78, 2019 | 14 | 2019 |
| Thiazolidinediones abrogate cervical cancer growth BR Wuertz, L Darrah, J Wudel, FG Ondrey Experimental cell research 353 (2), 63-71, 2017 | 14 | 2017 |
| Functional activation of PPARγ in human upper aerodigestive cancer cell lines SK Wright, BR Wuertz, G Harris, R Abu Ghazallah, WA Miller, PM Gaffney, ... Molecular carcinogenesis 56 (1), 149-162, 2017 | 14 | 2017 |
| Safety and preclinical efficacy of aerosol pioglitazone on lung adenoma prevention in A/J mice DE Seabloom, AR Galbraith, AM Haynes, JD Antonides, BR Wuertz, ... Cancer Prevention Research 10 (2), 124-132, 2017 | 13 | 2017 |
| Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells MN Le, BR Wuertz, MA Biel, RL Thompson, FG Ondrey Laryngoscope investigative otolaryngology 7 (4), 982-987, 2022 | 9 | 2022 |
| Effects of PPAR‐γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies JA Hall, M Rusten, RD Abughazaleh, B Wuertz, V Souksavong, P Escher, ... Head & neck 42 (9), 2542-2554, 2020 | 9 | 2020 |
